EU Ordered To Reconsider Glaxo Request On Its Prices.

The article reports on the ruling of the European Court of Justice on October 6, 2009 which ordered regulators to consider a plea by GlaxoSmithKline PLC which requested for an exemption from competition policies in order to prevent parallel traders, who purchase drugs in markets that set price cap to resell them at higher value. It states the alleged violation of common-market policies by the firm, as claimed by the European Commission in 2001. The ruling supported a lower-court verdict about the failure of the commission to fully review the request.